Molly is Project Director of the Specialty Drug Evidence and Coverage (SPEC) database team. Her research focuses on the impact of US health plan coverage decisions on patients’ access to treatment. Prior to joining CEVR, Molly served as Senior Research Lead at the Institute for Clinical and Economic Review (ICER). Molly holds a dual BA in Biology and Psychology from Cornell University and an MPH from Boston University School of Public Health.